The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
CYCLIZINE ANS (Southern XP IP Pty Ltd)
Product name
CYCLIZINE ANS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
119 (255 working days)
Active ingredients
cyclizine lactate
Registration type
New generic medicine
Indication
CYCLIZINE ANS is indicated for the prevention of nausea and vomiting in the post-operative period.